Reviewing The Pennant Group (PNTG) & The Competition

The Pennant Group (NASDAQ:PNTGGet Rating) is one of 33 publicly-traded companies in the “Health services” industry, but how does it contrast to its competitors? We will compare The Pennant Group to related businesses based on the strength of its dividends, earnings, profitability, valuation, analyst recommendations, institutional ownership and risk.

Risk & Volatility

The Pennant Group has a beta of 2.35, indicating that its stock price is 135% more volatile than the S&P 500. Comparatively, The Pennant Group’s competitors have a beta of 1.48, indicating that their average stock price is 48% more volatile than the S&P 500.

Valuation & Earnings

This table compares The Pennant Group and its competitors top-line revenue, earnings per share (EPS) and valuation.

Gross Revenue Net Income Price/Earnings Ratio
The Pennant Group $439.69 million $2.70 million 493.75
The Pennant Group Competitors $1.36 billion -$98.47 million 29.15

The Pennant Group’s competitors have higher revenue, but lower earnings than The Pennant Group. The Pennant Group is trading at a higher price-to-earnings ratio than its competitors, indicating that it is currently more expensive than other companies in its industry.

Institutional & Insider Ownership

88.6% of The Pennant Group shares are owned by institutional investors. Comparatively, 48.6% of shares of all “Health services” companies are owned by institutional investors. 10.3% of The Pennant Group shares are owned by insiders. Comparatively, 21.6% of shares of all “Health services” companies are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Profitability

This table compares The Pennant Group and its competitors’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
The Pennant Group 0.22% 9.01% 2.08%
The Pennant Group Competitors -325.87% -481.74% -38.64%

Analyst Recommendations

This is a summary of recent ratings and target prices for The Pennant Group and its competitors, as provided by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
The Pennant Group 0 3 2 0 2.40
The Pennant Group Competitors 7 129 274 0 2.65

The Pennant Group currently has a consensus target price of $17.60, suggesting a potential upside of 78.32%. As a group, “Health services” companies have a potential upside of 121.39%. Given The Pennant Group’s competitors stronger consensus rating and higher probable upside, analysts clearly believe The Pennant Group has less favorable growth aspects than its competitors.

Summary

The Pennant Group beats its competitors on 7 of the 12 factors compared.

The Pennant Group Company Profile

(Get Rating)

The Pennant Group, Inc. provides healthcare services in the United States. It operates in two segments, Home Health and Hospice Services, and Senior Living Services. The company offers home health services, including clinical services, such as nursing, speech, occupational and physical therapy, medical social work, and home health aide services; and hospice services comprising clinical care, education, and counseling services for the physical, spiritual, and psychosocial needs of terminally ill patients and their families. It also provides senior living services, such as residential accommodations, activities, meals, housekeeping, and assistance in the activities of daily living to seniors, who are independent or who require some support. As of December 31, 2021, the company operated 88 home health and hospice agencies, and 54 senior living communities with 4127 Senior Living units in Arizona, California, Colorado, Idaho, Iowa, Montana, Nevada, Oklahoma, Oregon, Texas, Utah, Washington, Wisconsin, and Wyoming. The Pennant Group, Inc. was incorporated in 2019 and is headquartered in Eagle, Idaho.

Receive News & Ratings for The Pennant Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for The Pennant Group and related companies with MarketBeat.com's FREE daily email newsletter.